Surgery plus drug: a One-Two punch against obesity?
NCT ID NCT07633639
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a GLP-1 weight-loss drug after bariatric surgery helps people with obesity lose more weight and avoid regaining it. About 200 Chinese adults aged 18-60 who are having sleeve gastrectomy will be randomly assigned to get the drug or not. The goal is to see if the combination is safer and more effective than surgery alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China-Japan Friendship Hospital
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?